two consecutive days，Two multinational pharmaceutical companies set up a joint venture with Chinese local enterprises。
 
Yesterday (September 13)，Haizheng Pfizer Pharmaceutical Co., Ltd. (hereinafter referred to as Haizheng Pfizer), which has announced its joint venture by Hai Zheng Pharmaceutical and Pfizer;，Xianyin Pharmaceutical and Merhado also announced the establishment of a joint venture company Xianmoshanda (Shanghai) Pharmaceutical Co., Ltd.。
 
Whether it is Merhado stake sports betting appor stake sports betting appPfizer，The intention of setting up a joint venture with local pharmaceutical companies is to deeply plant China's grass -roots medical markets。
 
Marriage with local pharmaceutical companies
 
Haizheng Pfizer (Hai Zheng and Pfizer each account for 51%and 49%of the equity) will mainly engage in the production of brand generic drugs and expired patent drugs in China，Total investment 295 million US dollars，This is also the first time that Pfizer has been involved in the field of generic drugs in China。Pioneer Merhado will focus on the two major areas of cardiovascular and metabolic diseases。
 
The negotiations between Pfizer and Hemheng are quite discount，The two parties do not exclude his sexual terms，& ldquo; Otherwise, it may restrict the development of the parent company of both parties after binding，At present, Haizheng can continue to take preparations in China，Reserved the business of a certain preparation。& rdquo; A senior manager of Haizheng Pharmaceutical said in an interview with the media。
 
Chairman Bai Yan, chairman of Hemheng Pharmaceutical, said in an interview with "Daily Economic News" reporter，joint venture salary is currently facing the Chinese market，But I will soon enter the international market，& ldquo; I am still waiting for FDA approval & rdquo;。& ldquo; Sales has always been our shortcomings，We also hope to use Pfizer's sales advantage to enter stake online sports bettingthe stake betting appglobal market。& rdquo;
 
Pioneer Merhado (Merhado and the first voice each account for 51%and 49%of the equity) to focus on the domestic market，Temporary does not involve international markets。According to Zhang Yehong, CEO of Murdo Merhado, reveal to reporters，In some aspects, the two parties signed the exclusive terms，Some products can only be sold through a joint venture。
 
Both joint venture companies said，Its goals are not just drugs in patents，It will soon be committed to product development。
 
& ldquo; Many multinational pharmaceutical giants, including Pfizer, are competing for the Chinese imitation drug market，Although the size of the Chinese generic drug market is large，But high -level imitation drug insufficient。& rdquo; Some people in the industry said。
 
Deep cultivation of the Chinese market
 
Zhang Yehong expressed the intention of cultivating the Chinese market in an interview with reporters，& ldquo; The company hopes to expand the target market from the eastern coast to the rural market，and will enter the grass -roots market (such as municipal health centers), etc.，and it is expected that 7 products will enter the international basic directory next year。& rdquo;
 
Hai Zhengfang CEO Xiao Weihong also said at the press conference，Haizheng Pfizer's goal is to occupy 95%of the first -level hospital 90%of the secondary hospital and 75%of the third -level hospital。
 
Some people in the industry stake sports betting appStake Sports Bettingtold reporters，The reason why Merhadon chose to cooperate with the pioneer pharmaceutical，It is because the pioneer pharmaceutical industry has been working in the industry for many years，I have accumulated a lot of market channels and public relations，and this is the place that foreign enterprises are most likely。There are these resources and channels，Foreign -funded pharmaceutical companies will be smoother when entering the country。Data display，The sales network of Xianmin Pharmaceutical has covered more than 4,000 hospitals and more than 70,000 pharmacies nationwide，With more than 800 sales staff。
 
The aforementioned industry person told reporters，The current multinational pharmaceutical company is facing the two major crisis of patent expiration and the price reduction of the original drugs，In this case，Obtain market expansion by acquiring or joining high -quality local pharmaceutical companies，It is becoming a new strategy that is expanding in China。& ldquo; Cooperation of multinational pharmaceutical companies and Chinese companies，More importantly is the expansion of market share，But its market expansion in China、The understanding of Chinese policy is not as good as local companies。Cooperate with local companies、Sales can reduce related costs。